Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Biodesix (BDSX) Accumulated Depreciation & Amortization (2019 - 2025)

Biodesix's Accumulated Depreciation & Amortization history spans 7 years, with the latest figure at $12.5 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 37.03% year-over-year to $12.5 million; the TTM value through Dec 2025 reached $12.5 million, up 37.03%, while the annual FY2025 figure was $12.5 million, 37.03% up from the prior year.
  • Accumulated Depreciation & Amortization reached $12.5 million in Q4 2025 per BDSX's latest filing, up from $11.7 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $12.5 million in Q4 2025 to a low of $5.6 million in Q4 2023.
  • Average Accumulated Depreciation & Amortization over 5 years is $8.1 million, with a median of $7.4 million recorded in 2021.
  • Peak YoY movement for Accumulated Depreciation & Amortization: dropped 20.03% in 2023, then surged 62.76% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $6.7 million in 2021, then rose by 3.99% to $7.0 million in 2022, then fell by 20.03% to $5.6 million in 2023, then soared by 62.76% to $9.1 million in 2024, then surged by 37.03% to $12.5 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Accumulated Depreciation & Amortization are $12.5 million (Q4 2025), $11.7 million (Q3 2025), and $10.8 million (Q2 2025).